Financhill
Sell
25

SYRS Quote, Financials, Valuation and Earnings

Last price:
$0.21
Seasonality move :
5.18%
Day range:
$0.20 - $0.22
52-week range:
$0.18 - $8.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
8.06x
Volume:
2.8M
Avg. volume:
17.6M
1-year change:
-96.23%
Market cap:
$5.5M
Revenue:
$9.9M
EPS (TTM):
-$3.07

Earnings Data

Next earnings date for SYRS
Mar 27
2025
Most recent earnings per share
-$0.16
Beat by $0.51
(Oct 31/2024)
Consensus Estimate
-$0.67
(Oct 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SYRS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/27/2025 Q4 $450K -- -- -$0.71 --
10/31/2024 Q3 $360K -- -$0.16 -$0.67 $0.51
07/31/2024 Q2 $460K -- -$0.59 -$0.77 $0.18
05/14/2024 Q1 $720K -- -$0.10 -$0.94 $0.84
03/27/2024 Q4 $2M $386K -$2.22 -$1.12 -$1.11
11/14/2023 Q3 -- -- -$1.43 -$1.14 -$0.29
08/08/2023 Q2 -- -- -$1.30 -$1.13 -$0.17
05/10/2023 Q1 -- -- -$0.85 -$1.04 $0.19
03/02/2023 Q4 -- -- -$0.24 -$1.36 $1.12
11/14/2022 Q3 -- -- -$3.21 -$4.40 $1.19
08/09/2022 Q2 -- -- -$5.40 -- --
05/16/2022 Q1 -- -- -$3.99 -- --
03/15/2022 Q4 -- -- -$3.78 -- --
11/05/2021 Q3 -- -- -$4.14 -- --
08/05/2021 Q2 -- -- -$3.60 -- --
05/06/2021 Q1 -- -- -$2.30 -- --
03/04/2021 Q4 -- -- -$6.30 -- --
11/05/2020 Q3 -- -- -$4.30 -- --
08/06/2020 Q2 -- -- -$3.80 -- --
05/07/2020 Q1 -- -- -$3.90 -- --
03/05/2020 Q4 -- -- -$4.60 -- --
11/12/2019 Q3 -- -- -$4.70 -- --
08/01/2019 Q2 -- -- -$4.70 -- --
05/01/2019 Q1 -- -- -$4.90 -- --
03/07/2019 Q4 -- -- -$5.40 -- --
11/01/2018 Q3 -- -- -$4.70 -- --
08/07/2018 Q2 -- -- -$4.30 -- --
05/10/2018 Q1 -- -- -$4.80 -- --
03/12/2018 Q4 -- -- -$5.80 -- --
11/08/2017 Q3 -- -- -$5.30 -- --
08/09/2017 Q2 -- -- -$5.20 -- --
03/31/2017 Q1 -- -- -$4.90 -- --
03/20/2017 Q4 -- -- -$4.69 -- --
09/30/2016 Q3 -- -- -$6.50 -- --
06/30/2016 Q2 -- -- -$54.20 -- --
03/31/2016 Q1 -- -- -$5.42 -- --
12/31/2015 Q4 -- -- -$46.74 -- --
09/30/2015 Q3 -- -- -$38.02 -- --
06/30/2015 Q2 -- -- -$28.70 -- --
03/31/2015 Q1 -- -- -$3.22 -- --

Syros Pharmaceuticals Earnings Questions

  • How Much did Syros Pharmaceuticals Generate in Revenue Last Quarter?

    Syros Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Syros Pharmaceuticals Beat Earnings Last Quarter?

    Syros Pharmaceuticals announced earnings per share of -$0.16 which represents a beat of analyst forecast a -$0.67 per share.

  • Is Syros Pharmaceuticals Profitable?

    Syros Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Syros Pharmaceuticals EPS Next Year?

    Syros Pharmaceuticals's earnings are forecast to decrease from -$5.81 per share to -$4.72 per share next year representing a decrease of -73.02%.

  • When is Syros Pharmaceuticals's Earnings Date?

    Syros Pharmaceuticals's next earnings date is March 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock